For The Better

The electric vehicle manufacturer just told investors what they wanted to hear.

Is China finally ready to compromise with the Public Company Accounting Oversight Board?

Hims and Hers is rapidly expanding its brand across multiple healthcare categories.

Investors are excited about a potential stock split.

Gross profit margin compression is seen turning around for the online pet retailer.

It helps to have plenty of cold, hard cash.

The current economic backdrop gives this athleisure pioneer a chance to shine.

It takes more than a price drop to make a bargain.

The company dosed the first patient in a phase 1/2 study of its gene therapy candidate targeting a rare eye disease.

This crucial metric often gets overlooked by investors, but it shouldn’t.

Lucrative international travel was squashed during COVID-19. Now it faces a war.

In-person events might finally come back in full swing.

CALA earnings call for the period ending December 31, 2021.

Adopting a long-term mindset, while focusing on the fundamentals, will benefit investors in this situation.

Rate hikes shouldn’t rattle these stocks as their businesses carry relatively modest debt.

These two dividend stocks are proven safe havens.

The two blue-chip chipmakers are only superficially similar.

Buyers are desperate to see home values drop. Will that actually happen this year?